On October 10, 2025, S&P Global (SPGI) and CME Group announced the completion of their sale of OSTTRA, a joint venture, to KKR for a total enterprise value of $3.1 billion, with proceeds split evenly between the two companies. This transaction marks a significant portfolio move for S&P Global, enhancing its financial flexibility. Despite broad market declines (S&P 500 down 1.86%, NASDAQ down 2.36%), SPGI shares are trading at $488.12 (+0.10%), indicating relative resilience and suggesting that the OSTTRA sale is being viewed positively by investors, offsetting negative market sentiment.